Brief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
23/09/2026 15:11
BRIEF-Prostatype Genomics Cannot Specify Timing For Final Medicare Decision Sept 23 (Reuters) - Prostatype Genomics AB PROGEN.ST:
CANNOT SPECIFY TIMING FOR FINAL MEDICARE DECISION
Source text: ID:nMFN64fNjX
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue